Minimally invasive surgery involves the surgical procedure performed with minute incisions on the body. The surgeries include joint replacement, arthroscopic repairs of sports injuries, and microscopic treatment of complex musculoskeletal conditions among others. The benefits of minimally invasive surgery includes short recovery time, low risk of infection, less bleeding, small scars, and shorter hospital stays.
Minimally invasive techniques provide many benefits, including shorter hospital stays, faster recovery periods, less discomfort following surgery, and a decreased chance of problems, which are being favored by patients and healthcare professionals in the area as alternatives to open surgical procedures. The demand for orthopedic implants that work with minimally invasive methods-such as smaller implants, specialized surgical techniques, and instruments—is being driven by this shift towards MIS procedures. Thus, the focus towards adoption of minimally invasive surgery is expected to act as a driver for the market growth.
Access full Report @ https://www.databridgemarketresearch.com/jp/reports/mena-orthopedic-implants-market
Data Bridge Market Research analyzes that the MENA Orthopedic Implants Market is expected to reach USD 683.06 million by 2031 from USD 477.03 million in 2023, growing at a CAGR of 4.6% in the forecast period of 2024 to 2031.
Key Findings of the Study
Rising Prevalence of Orthopedic Disorders Along with Sports Injuries
There is a rising need for orthopedic implants to treat the musculoskeletal problems such as musculoskeletal disorders (MSD), muscle pain and others. Since the ageing populations, sedentary lifestyles, and increased sports engagement all contribute to a higher incidence of orthopedic disorders. The need for orthopedic therapies is being driven by serious injuries like fractures and ligament breaks from sporting activities, as well as chronic disorders like osteoarthritis and osteoporosis. Sports-related injuries are becoming more prevalent. Orthopedic implants and surgical procedures are frequently needed for these injuries in order to stabilize joints, repair ligaments, and treat fractures. As a result of this, it is anticipated that there will be a considerable increase in the need for orthopedic implants that are compatible with sports medicine operations.t
The urgent need for orthopedic therapies is highlighted by the rising prevalence of diseases such osteoarthritis, osteoporosis, and musculoskeletal injuries, which are further exacerbated by changes in demographics and lifestyle. Furthermore, the region's increased engagement in sports and physical activities has resulted in a rise in sports-related injuries, necessitating for the usage of orthopedic implants and surgical procedures for fracture repair, ligament restoration, and joint stabilization. Thus, the rising prevalence of orthopedic disorders along with sports injuries is expected to act a driver for market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Products (Spinal Implants and Trauma Implants), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Others), Mode (Open Surgery and Minimally Invasive Surgery (MIS)), Device Type (Internal Fixation Devices and External Fixation Devices), Application (Spine Fracture, Hip Replacement, Knee Replacement, Shoulder Replacement, Neck Fracture and Others), End User (Hospitals, Ambulatory Care Center, Specialty Clinics, Orthopedic Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others)
|
|
Countries Covered
|
Saudi Arabia, U.A.E., Egypt, Qatar, Kuwait, Oman, and Bahrain
|
|
Market Players Covered
|
Stryker (U.S.), Arthrex Inc. (Germany), CONMED Corporation (U.S.), B. Braun SE (Germany), Globus Medical (U.S.), Auxein (U.S.), Matrix Meditec (India), Medtronic (U.S.), Norm Medical (Turkey), and Orthomed (Egypt) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis
The MENA orthopedic implants market is segmented into seven notable segments based on products, biomaterial, mode, device type, application, end user, and distribution channel.
- On the basis of products, the market is segmented into spinal implants, and trauma implants
In 2024, the spinal implants segment is expected to dominate the MENA Orthopedic Implants Market
In 2024, the spinal implants segment is expected to dominate the market with a market share of 58.73% due to the increasing prevalence of orthopedic disorders.
- On the basis of biomaterial, the market is segmented into metallic biomaterials, polymeric biomaterials, ceramic biomaterials, natural biomaterials, others
In 2024, the metallic biomaterials segment is expected to dominate the MENA Orthopedic Implants Market
In 2024, the metallic biomaterials segment is expected to dominate the market with a market share of 47.37% due to the increasing focus towards minimally invasive surgery.
- On the basis of mode, the market is segmented into open surgery, and minimally invasive surgery (MIS). In 2024, the open surgery segment is expected to dominate the market with a market share of 67.01%
- On the basis of device type, the market is segmented into internal fixation devices, and external fixation devices. In 2024, the internal fixation devices segment is expected to dominate the market with a market share of 62.82%
- On the basis of application, the market is segmented into spine fracture, hip replacement, knee replacement, shoulder replacement, neck fracture, and others. In 2024, the spine fracture segment is expected to dominate the market with a market share of 30.74%
- On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, orthopaedic centers and others. In 2024, the hospitals segment is expected to dominate the market with a market share of 47.60%
- On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others. In 2024, the direct tenders segment is expected to dominate the market with a market share of 64.28%
Major Players
Data Bridge Market Research analyzes Stryker (U.S.), Arthrex Inc. (Germany), CONMED Corporation (U.S.), B. Braun SE (Germany), Globus Medical (U.S.) as the major companies operating in the MENA orthopedic implants market.
Market Developments
- In February 2024, Auxein Medical, a manufacturer and exporter of orthopaedic implants, is showcasing its latest innovations in medical technology at Arab Health, held at the World Trade Centre from January 29th to February 1st. The company is unveiling new products in the Trauma and Arthroscopy categories, along with a comprehensive range of advanced orthopaedic implants at stand CC99 in the concourse. Participating in Arab Health and showcasing new products will enhance Auxein Medical's brand visibility and attract potential customers, leading to increased sales and market expansion
- In January 2024, Arthrex, Inc. launched a new patient-focused portal named TheNanoExperience.com which highlights the science and advantages of nano arthroscopy, an innovative, minimally invasive orthopaedic technique that may enable rapid recovery to activity and reduced discomfort. Surgeons can diagnose and treat orthopaedic injuries in a variety of joint spaces, especially in smaller joints like the elbow, wrist, and ankle. They can also use Nano arthroscopy for injured or arthritic knees and shoulders. These procedures are made possible by a tiny, high-quality camera at the tip of a needle-like device, along with other miniature arthroscopic instruments
- In December 2023, Stryker announced that it has completed a legally-binding offer to Menix for the acquisition of SERF SAS. SERF SAS is well-known among medical professionals throughout the globe for its advancements in hip implants, which include the creation of the first Dual Mobility Cup. By adding this acquisition, Stryker would be able to offer improved service to a larger patient base and expand its global joint replacement portfolio
- In December 2023, B. Braun SE has introduced the CARESITE Micro Luer Access Device, aimed at minimizing exposure to hazardous chemicals and lowering the risk of infection. This innovation is intended to enhance the safety of IV access for both patients and healthcare providers. This will enhance B. Braun's market position by offering a safer IV access solution, attracting new customers, and reinforcing its reputation for innovation and safety
- In September 2023, Globus Medical, Inc., a prominent musculoskeletal solutions company, has announced its commitment to EUROSPINE by extending its silver sponsorship and confirming its participation in EUROSPINE 2023. This continued partnership and sponsorship with EUROSPINE will enhance the visibility and reputation of Globus Medical, Inc. within the spine surgery community, potentially leading to increased brand recognition and business opportunities
Geographical Analysis
Geographically, the countries covered in the MENA orthopedic implants market report are the Saudi Arabia, U.A.E., Egypt, Qatar, Kuwait, Oman, and Bahrain.
As per Data Bridge Market Research analysis:
Saudi Arabia is expected to be the dominant and fastest growing country in the MENA Orthopedic Implants Market
Saudi Arabia is expected to dominate the orthopedic implants market owing to the rising healthcare expenditure. Also, it is expected to be the fastest growing country since government is investing in research based activities and growing prevalence of orthopedic disorders.
For more detailed information about the MENA Orthopedic Implants Market report, click here – https://www.databridgemarketresearch.com/jp/reports/mena-orthopedic-implants-market
